The antiestrogenic role of GbE has been linked to competition with estrogens for ER-β binding, pointing GbE as a chemopreventive agent for breast cancer development, an important side effect of HRT (Oh and Chung, 2004, 2006). This evidence concerns the gene ESR2 and breast carcinoma.